Nutcracker Therapeutics, Inc. — Form D
Nutcracker Therapeutics, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-07. The offering totals $200.0M, of which $144.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-07
- Form: D
- Accession: 0001741042-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200.0M
- Amount sold: $144.5M
- Remaining: $55.5M
- Investors: 14
- Date of first sale: 2021-08-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-412462
Issuer
- Name: Nutcracker Therapeutics, Inc.
- CIK: 0001741042
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 5858 HORTON STREET, EMERYVILLE, CA, 94608
- Phone: (510) 473-8478
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Igor Khandros | Director | Santa Clara, CA |
| Robert Nelsen | Director | Seattle, WA |
| Madhavan Balachandran | Executive Officer | Agoura Hills, CA |
| Samuel Deutsch | Executive Officer | Emeryville, CA |
| Benjamin Eldridge | Executive Officer | Emeryville, CA |
| Igor Khandros | Executive Officer | Santa Clara, CA |
| James Zhu | Executive Officer | Emeryville, CA |
Other filings by this issuer (3)
More